TETRAPHASE PHARMACEUTICALS I - COM (TTPH) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2019

Type / Class
Equity / COM
Symbol
TTPH
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2019 Q3 0 $0 -$8,222,205 0
2019 Q2 17,133,363 $8,225,777 -$3,017,160 $0.48 60
2019 Q1 20,981,027 $28,114,608 -$3,339,341 $1.34 75
2018 Q4 23,639,637 $26,708,287 -$423,167 $1.13 82
2018 Q3 22,954,526 $63,358,691 +$2,229,773 $2.76 87
2018 Q2 21,705,374 $77,484,208 -$3,897,674 $3.57 87
2018 Q1 23,027,775 $70,693,154 -$39,154,608 $3.07 88
2017 Q4 30,255,960 $190,611,820 +$1,184,065 $6.30 99
2017 Q3 29,895,873 $204,194,926 +$57,843,669 $6.84 91
2017 Q2 21,300,732 $151,872,716 +$19,324,322 $7.13 89
2017 Q1 18,494,977 $169,962,827 +$27,159,351 $9.19 87
2016 Q4 18,011,916 $72,574,705 -$8,859,291 $4.03 88
2016 Q3 20,217,056 $77,432,668 -$6,326,626 $3.83 89
2016 Q2 21,825,025 $93,840,092 -$7,846,673 $4.30 90
2016 Q1 23,467,200 $108,664,000 -$21,707,431 $4.63 98
2015 Q4 26,370,648 $264,488,978 -$12,090,350 $10.03 102
2015 Q3 28,301,045 $211,111,390 -$214,788,430 $7.46 102
2015 Q2 27,440,697 $1,301,911,329 +$100,257,417 $47.44 136
2015 Q1 25,579,007 $937,178,454 +$147,668,954 $36.64 130
2014 Q4 20,920,293 $830,689,217 +$300,191,506 $39.71 96
2014 Q3 14,326,215 $285,623,338 +$47,336,482 $19.95 73
2014 Q2 12,140,937 $163,780,213 -$23,002,496 $13.49 63
2014 Q1 13,902,546 $149,740,869 +$3,137,769 $10.89 64